Robert W. Baird reaffirmed their hold rating on shares of LHC Group (NASDAQ:LHCG) in a research note released on Friday. The firm currently has a $69.00 price objective on the health services provider’s stock.

Several other research analysts also recently issued reports on LHCG. Royal Bank Of Canada reiterated a buy rating and set a $69.00 price target on shares of LHC Group in a research report on Tuesday, July 18th. BidaskClub cut LHC Group from a buy rating to a hold rating in a report on Tuesday, July 25th. Zacks Investment Research raised LHC Group from a hold rating to a buy rating and set a $67.00 price objective for the company in a report on Saturday, August 5th. Jefferies Group LLC reissued a buy rating and set a $68.00 price objective on shares of LHC Group in a report on Friday, August 4th. Finally, Bank of America Corporation began coverage on LHC Group in a report on Monday, August 21st. They set a buy rating and a $76.00 price objective for the company. Two research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. The company has a consensus rating of Buy and a consensus target price of $76.40.

LHC Group (NASDAQ:LHCG) opened at $67.81 on Friday. The stock has a market cap of $1,211.21, a PE ratio of 28.44, a P/E/G ratio of 1.96 and a beta of 0.70. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.24. LHC Group has a 52-week low of $41.66 and a 52-week high of $76.14.

LHC Group (NASDAQ:LHCG) last issued its quarterly earnings results on Monday, November 6th. The health services provider reported $0.64 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.60 by $0.04. The business had revenue of $272.90 million for the quarter, compared to the consensus estimate of $265.35 million. LHC Group had a net margin of 4.09% and a return on equity of 9.52%. The firm’s quarterly revenue was up 18.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.54 EPS. analysts forecast that LHC Group will post 2.4 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/11/14/lhc-group-lhcg-earns-hold-rating-from-robert-w-baird.html.

In other news, COO Donald Dwayne Stelly sold 2,650 shares of the company’s stock in a transaction dated Friday, September 8th. The stock was sold at an average price of $65.34, for a total value of $173,151.00. Following the completion of the sale, the chief operating officer now directly owns 109,235 shares of the company’s stock, valued at approximately $7,137,414.90. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 14.80% of the company’s stock.

Several hedge funds have recently made changes to their positions in LHCG. UBS Asset Management Americas Inc. bought a new stake in shares of LHC Group in the 1st quarter valued at about $248,000. Principal Financial Group Inc. increased its stake in LHC Group by 3.6% during the 1st quarter. Principal Financial Group Inc. now owns 113,707 shares of the health services provider’s stock worth $6,129,000 after purchasing an additional 3,983 shares in the last quarter. Legal & General Group Plc increased its stake in LHC Group by 1.2% during the 1st quarter. Legal & General Group Plc now owns 25,087 shares of the health services provider’s stock worth $1,353,000 after purchasing an additional 290 shares in the last quarter. Thrivent Financial For Lutherans increased its stake in LHC Group by 4.1% during the 1st quarter. Thrivent Financial For Lutherans now owns 8,380 shares of the health services provider’s stock worth $452,000 after purchasing an additional 330 shares in the last quarter. Finally, Vanguard Group Inc. increased its stake in LHC Group by 3.9% during the 1st quarter. Vanguard Group Inc. now owns 1,432,008 shares of the health services provider’s stock worth $77,185,000 after purchasing an additional 54,279 shares in the last quarter. 87.29% of the stock is owned by institutional investors.

LHC Group Company Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Stock Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related stocks with our FREE daily email newsletter.